Bayer's stock price surges 12% following a significant legal victory in the United States against claims linking Roundup to cancer.
Bayer's shares rose in early trading after the company announced a legal victory in its lawsuit against allegations that Roundup weed killer exposure caused cancer.
The stock was up 11.67% at 11:44 a.m. London time.
On Thursday, the 3rd U.S. Circuit Court of Appeals in Philadelphia ruled in favor of the company against plaintiff David Schaffner's claim that Bayer, which acquired Monsanto in 2018, violated state law by not adding a cancer warning to the Roundup label.
This breaking news story is being updated.
Markets
You might also like
- Banco BPM to be Acquired by UniCredit for $10.5 Billion
- Can Saudi Arabia sustain its rapid spending on ambitious mega-projects?
- The cost of Russian food is increasing, yet nobody is accusing Putin or the conflict of the rise.
- In Laos, six travelers are believed to have died from methanol poisoning. This is where such incidents are most common.
- Precious metal investors are being distracted by the allure of the crypto rally, according to State Street.